254 related articles for article (PubMed ID: 37032646)
1. Nanopore sequencing reveals methylation changes associated with obesity in circulating cell-free DNA from Göttingen Minipigs.
Drag MH; Debes KP; Franck CS; Flethøj M; Lyhne MK; Møller JE; Ludvigsen TP; Jespersen T; Olsen LH; Kilpeläinen TO
Epigenetics; 2023 Dec; 18(1):2199374. PubMed ID: 37032646
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA methylation reveals cell-specific tissue injury and correlates with disease severity and patient outcomes in COVID-19.
Li YY; Yuan MM; Li YY; Li S; Wang JD; Wang YF; Li Q; Li J; Chen RR; Peng JM; Du B
Clin Epigenetics; 2024 Mar; 16(1):37. PubMed ID: 38429730
[TBL] [Abstract][Full Text] [Related]
3. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma.
Yu SCY; Deng J; Qiao R; Cheng SH; Peng W; Lau SL; Choy LYL; Leung TY; Wong J; Wong VW; Wong GLH; Jiang P; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2023 Feb; 69(2):168-179. PubMed ID: 36322427
[TBL] [Abstract][Full Text] [Related]
5. Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing.
Lau BT; Almeda A; Schauer M; McNamara M; Bai X; Meng Q; Partha M; Grimes SM; Lee H; Heestand GM; Ji HP
Genome Med; 2023 May; 15(1):33. PubMed ID: 37138315
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide detection of imprinted differentially methylated regions using nanopore sequencing.
Akbari V; Garant JM; O'Neill K; Pandoh P; Moore R; Marra MA; Hirst M; Jones SJM
Elife; 2022 Jul; 11():. PubMed ID: 35787786
[TBL] [Abstract][Full Text] [Related]
7. Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M; Verma RK; Kumar S; Kumar V
Comput Struct Biotechnol J; 2022; 20():26-39. PubMed ID: 34976309
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
9. Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer.
Liang L; Zhang Y; Li C; Liao Y; Wang G; Xu J; Li Y; Yuan G; Sun Y; Zhang R; Li X; Nian W; Zhao J; Zhang Y; Zhu X; Wen X; Cai S; Li N; Wu L
EBioMedicine; 2022 Sep; 83():104222. PubMed ID: 35973389
[TBL] [Abstract][Full Text] [Related]
10. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation biomarkers for noninvasive detection of triple-negative breast cancer using liquid biopsy.
Manoochehri M; Borhani N; Gerhäuser C; Assenov Y; Schönung M; Hielscher T; Christensen BC; Lee MK; Gröne HJ; Lipka DB; Brüning T; Brauch H; Ko YD; Hamann U
Int J Cancer; 2023 Mar; 152(5):1025-1035. PubMed ID: 36305646
[TBL] [Abstract][Full Text] [Related]
13. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma.
Patel KB; Padhya TA; Huang J; Hernandez-Prera JC; Li T; Chung CH; Wang L; Wang X
Mol Carcinog; 2023 Apr; 62(4):493-502. PubMed ID: 36636912
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Plasma Cell-Free DNA Methylation Profiling Identifies Potential Biomarkers for Lung Cancer.
Xu W; Lu J; Zhao Q; Wu J; Sun J; Han B; Zhao X; Kang Y
Dis Markers; 2019; 2019():4108474. PubMed ID: 30867848
[TBL] [Abstract][Full Text] [Related]
16. Cas9-targeted nanopore sequencing reveals epigenetic heterogeneity after
Goldsmith C; Cohen D; Dubois A; Martinez MG; Petitjean K; Corlu A; Testoni B; Hernandez-Vargas H; Chemin I
Microb Genom; 2021 May; 7(5):. PubMed ID: 34003741
[TBL] [Abstract][Full Text] [Related]
17. Adipose cell-free DNA in diabetes.
Humardani FM; Mulyanata LT; Dwi Putra SE
Clin Chim Acta; 2023 Jan; 539():191-197. PubMed ID: 36549639
[TBL] [Abstract][Full Text] [Related]
18. EpiPanGI Dx: A Cell-free DNA Methylation Fingerprint for the Early Detection of Gastrointestinal Cancers.
Kandimalla R; Xu J; Link A; Matsuyama T; Yamamura K; Parker MI; Uetake H; Balaguer F; Borazanci E; Tsai S; Evans D; Meltzer SJ; Baba H; Brand R; Von Hoff D; Li W; Goel A
Clin Cancer Res; 2021 Nov; 27(22):6135-6144. PubMed ID: 34465601
[TBL] [Abstract][Full Text] [Related]
19. Differentially hypomethylated cell-free DNA and coronary collateral circulation.
Ahn J; Heo S; Ahn SJ; Bang D; Lee SH
Clin Epigenetics; 2022 Nov; 14(1):140. PubMed ID: 36320085
[TBL] [Abstract][Full Text] [Related]
20. Identification of cell-free DNA methylation patterns unique to the human left ventricle as a potential indicator of acute cellular rejection.
Pattar S; Aleinati M; Iqbal F; Madhu A; Blais S; Wang X; Dallaire F; Wang Y; Isaac D; Fine N; Greenway SC
Clin Transplant; 2021 Jun; 35(6):e14295. PubMed ID: 33756005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
